mRNA Expression in Rabbit Experimental Aneurysms: A Study Using Gene Chip Microarrays

References

1. ↵
   Khurana VG, Smith LA, Baker TA, et al. Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 2002;33:782–89

   Abstract/FREE Full Text
2. ↵
   Khurana VG, Sohni YR, Mangrum WI, et al. Section on cerebrovascular surgery: Galbraith Award: Endothelial nitric oxide synthase (eNOS) and heme oxygenase-1 (HO-1) gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage (SAH) and post-SAH cerebral vasospasm. Clin Neurosurg 2004;51:343–50

   PubMed
3. ↵
   Ribourtout E, Raymond J. Gene therapy and endovascular treatment of intracranial aneurysms. Stroke 2004;35:786–93

   Abstract/FREE Full Text
4. Abrahams JM, Forman MS, Grady MS, et al. Delivery of human vascular endothelial growth factor with platinum coils enhances wall thickening and coil impregnation in a rat aneurysm model. AJNR Am J Neuroradiol 2001;22:1410–17

   Abstract/FREE Full Text
5. ↵
   Peters DG, Kassam A, St Jean PL, et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 1999;30:2612–16

   Abstract/FREE Full Text
6. ↵
   Stehbens WE. The ultrastructure of experimental aneurysms in rabbits. Pathology 1985;17:87–95

   PubMedWeb of Science
7. Stehbens WE. In re: histological and morphologic comparison of experimental aneurysms with human intracranial aneurysms. AJNR Am J Neuroradiol 2000;21:1769–73

   FREE Full Text
8. ↵
   Abruzzo T, Shengelaia GG, Dawson RC 3rd, et al. Histologic and morphologic comparison of experimental aneurysms with human intracranial aneurysms. AJNR Am J Neuroradiol 1998;19:1309–14

   Abstract
9. ↵
   Altes TA, Cloft HJ, Short JG, et al. 1999 ARRS Executive Council Award. Creation of saccular aneurysms in the rabbit: a model suitable for testing endovascular devices. American Roentgen Ray Society. AJR Am J Roentgenol 2000;174:349–54

   CrossRefPubMedWeb of Science
10. ↵
    Peters DG, Kassam AB, Feingold E, et al. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001;32:1036–42

    Abstract/FREE Full Text
11. ↵
    Krex D, Schackert HK, Schackert G. Genesis of cerebral aneurysms—an update. Acta Neurochirurgica 2001;143:429–48; discussion 448–49

    CrossRefPubMed
12. ↵
    Takagi Y, Ishikawa M, Nozaki K, et al. Increased expression of phosphorylated c-Jun amino-terminal kinase and phosphorylated c-Jun in human cerebral aneurysms: role of the c-Jun amino-terminal kinase/c-Jun pathway in apoptosis of vascular walls. Neurosurgery 2002;51:997–1002; discussion 1002–04

    CrossRefPubMedWeb of Science
13. ↵
    Fukuda, S., et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 2000;101:2532–38

    Abstract/FREE Full Text
14. Ohkuma, H., et al. Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation 2003;108:785–87

    Abstract/FREE Full Text
15. ↵
    Zhang B, Fugleholm K, Day LB, et al. Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003;35:1341–60

    CrossRefPubMedWeb of Science
16. ↵
    Bruno G, Todor R, Lewis I, et al. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg 1998;89:431–40

    PubMedWeb of Science
17. St Jean P, Hart B, Webster M, et al. Alpha-1-antitrypsin deficiency in aneurysmal disease. Hum Hered 1996;46:92–97

    CrossRefPubMedWeb of Science
18. ↵
    Todor DR, Lewis I, Bruno G, et al. Identification of a serum gelatinase associated with the occurrence of cerebral aneurysms as pro-matrix metalloproteinase-2. Stroke 1998;29:1580–83

    Abstract/FREE Full Text
19. ↵
    Kim SC, Singh M, Huang J, et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997;41:642–66; discussion 646–47

    CrossRefPubMedWeb of Science
20. ↵
    Zhao J, Han L, Wang S. In situ localization of mRNA gelatinases in cerebral aneurysms. Chung-Hua i Hsueh Tsa Chih 1999;79:822–24
21. ↵
    Mimata C, Kitaoka M, Nagahiro S, et al. Differential distribution and expressions of collagens in the cerebral aneurysmal wall. Acta Neuropathologica 1997;94:197–206

    CrossRefPubMed
22. Ostergaard JR, Reske-Nielsen E, Buhl J. Deficiency of reticular fibers in cerebral arteries. On the etiology of saccular aneurysms in childhood. Br J Neurosurg 1989;3:113–15

    CrossRefPubMed
23. Neil-Dwyer G, Bartlett JR, Nicholls AC, et al. Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg 1983;59:16–20

    PubMedWeb of Science
24. Pope FM, Nicholls AC, Narcisi P, et al. Some patients with cerebral aneurysms are deficient in type III collagen. Lancet 1981;1:973–75

    PubMedWeb of Science
25. ↵
    Majamaa K, Savolainen ER, Myllyla VV. Synthesis of structurally unstable type III procollagen in patients with cerebral artery aneurysm. Biochim Biophys Acta 1992;1138:191–96

    PubMed
26. ↵
    Brooks AR, Lelkes PI, Rubanyi GM. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics 2002;9:27–41

    Abstract/FREE Full Text
27. Absi TS, Sundt TM 3rd, Tung WS, et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thoracic Cardiovasc Surg 2003;126:344–57; discussion 357

    CrossRefPubMedWeb of Science
28. Armstrong PJ, Johanning JM, Calton WC Jr, et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 2002;35:346–55

    CrossRefPubMedWeb of Science
29. ↵
    Tung WS, Lee JK, Thompson RW. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 2001;34:143–50

    CrossRefPubMedWeb of Science
30. ↵
    Yajima N, Masuda M, Miyazaki M, et al. Oxidative stress is involved in the development of experimental abdominal aortic aneurysm: a study of the transcription profile with complementary DNA microarray. J Vasc Surg 2002;36:379–85

    CrossRefPubMedWeb of Science
31. Dunn LT, Stewart E, Murray GD, et al. The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study. Neurosurgery 1006;48:1006–10
32. Khurana VG, Sohni YR, Mangrum WI, et al. Endothelial nitric oxide synthase T-786C single nucleotide polymorphism: a putative genetic marker differentiating small versus large ruptured intracranial aneurysms. Stroke 2003;34:2555–59

    Abstract/FREE Full Text
33. ↵
    Suzuki Y, et al. Nitric oxide metabolites in the cisternal cerebral spinal fluid of patients with subarachnoid hemorrhage. Neurosurgery 1997;41:807–11; discussion 811–12

    CrossRefPubMed
34. ↵
    Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res 1998;20:127–30

    PubMedWeb of Science
35. ↵
    Kondo S, Hashimoto N, Kikuchi H, et al. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 1998;29:181–88; discussion 189

    Abstract/FREE Full Text
36. ↵
    Sakaki T, Kohmura E, Kishiguchi T, et al. Loss and apoptosis of smooth muscle cells in intracranial aneurysms. Studies with in situ DNA end labeling and antibody against single-stranded DNA. Acta Neurochir (Wien) 1997;139:469–74; discussion 474–75

    CrossRefPubMed
37. ↵
    Stehbens WE. Apoptosis and matrix vesicles in the genesis of arterial aneurysms of cerebral arteries. Stroke 1998;29:1478–80

    FREE Full Text
38. ↵
    Austin G, Fisher S, Dickson D, et al. The significance of the extracellular matrix in intracranial aneurysms. Ann Clin Lab Sci 1993;23:97–105

    Abstract/FREE Full Text
39. ↵
    Gaetani P, Rodriguez y Baena R, Tartara F, et al. Metalloproteases and intracranial vascular lesions. Neurol Res 1999;21:385–90

    CrossRefPubMed
40. ↵
    Eckel JE, Gennings C, Therneau TM, et al. Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics 2005;21:1078–83

    Abstract/FREE Full Text
41. ↵
    Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675–80

    CrossRefPubMedWeb of Science
42. ↵
    Sadamasa N, Nozaki K, Hashimoto N. Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 2003;34:2980–84

    Abstract/FREE Full Text
43. Coutard M. Experimental cerebral aneurysms in the female heterozygous Blotchy mouse. Int J Exp Pathol 1999;80:357–67

    CrossRefPubMed
44. Torres VE, Cai Y, Chen X, et al. Vascular expression of polycystin-2. J Am Soc Nephrol 2001;12:1–9

    Abstract/FREE Full Text
45. ↵
    Arnaout MA. The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models. Kidney Int 2000;58:2599–610

    CrossRefPubMed
46. ↵
    Lee DW, Yuki I, Murayama Y, et al. A histologic and molecular analysis of thrombus organization and healing in the swine experimental aneurysm model. Presentation at the American Society of Neuroradiology, San Diego, Calif; May 4,2006 .
47. ↵
    Sakomura Y, Nagashima H, Aoka Y, et al, Expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells is upregulated in cystic medial degeneration of annuloaortic ectasia in Marfan syndrome. Circulation 2002;106(12 Suppl 1):24